연구

연구업적

최근 5년 연구업적 현황
연도 2025년 2024년 2023년 2022년 2021년
SCI 논문
발표편수
책임 196편 179편 173편 163편 184편
공동 132편 147편 120편 115편 136편
합계 328편 326편 293편 278편 320편
3695. An updated review about the possibility of surveillance strategy in non-resected mucinous cystic neoplasms.
Yun WG, Jang JY.
J Hepatobiliary Pancreat Sci. 2025 Jan 3. Link
3694. Multiomic quantification of the KRAS mutation dosage improves the preoperative prediction of survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Yun WG, Kim D, Han Y, Kwon W, Lee SG, Jang JY, Park D.
Exp Mol Med. 2025 Jan 8. Link
3693. Efficacy of Neoadjuvant Radiotherapy After Chemotherapy and the Optimal Interval from Radiotherapy to Surgery for Borderline Resectable and Resectable Pancreatic Cancer.
Yun WG, Chae YS, Han Y, Jung HS, Cho YJ, Kang HC, Kwon W, Park JS, Chie EK, Jang JY.
Ann Surg Oncol. 2025 Jan 14. Link
3692. Changing Clinical Meaning of Resection Margin Status According to the Treatment Paradigm and the Potential Role of Perioperative Radiotherapy for Patients with Pancreatic Ductal Adenocarcinoma: An Updated Multicenter Retrospective Cohort Study.
Yun WG, Kwon W, Sohn HJ, Han Y, Chae YS, Jung HS, Cho YJ, Lim CS, Yoon YS, Jang JY.
Ann Surg Oncol. 2025 Apr 30. Link
3691. pH-responsive Oral liposomal delivery of hydrogen sulfide donor GYY4137 enables colon-targeted therapy for inflammatory bowel disease
Chiwoo Oh, Jee-Eun Hwang, Hyunjoon Yim, Heana Park, Seo-young Kim, Jae Kyoo Lee, and Hyung-Jun Im
Journal of Nanobiotechnology. 2025;23:712 Link
3690. Theranostic Gold Nanoparticles Encapsulated in a PEGylated Liposome as an Effective Radiosensitizer for Cancer Radiation Therapy
Jinyeong Choi, Gaeun Kim, Beomjin Park, Jiwoo Park, Shengjun Li, Wooseung Lee, Miyeon Jeon, Chiwoo Oh, Sangmin Lee, Sung-Joon Ye, Hyung-Jun Im
ACS Appl Bio Mater. 2025;8(9):7877-7888 Link
3689. Magnetic Resonance Imaging-Based Quantification of Endosomal Escape Using Iron Oxide Nanoparticle-Loaded Lipid Nanoparticles
Somin Lee, Jeongbin Park, Han Na Jung, Shengjun Li, Zhijun Lin, Hyung-Jun Im.
Adv Healthc Mater. 2025;14:e202503055. Link
3688. Nanomedicine and Spleen-Targeting Strategies for Precision Immunomodulation: Advances, Challenges, and Future Perspectives
Chiwoo Oh, Han Na Jung, Jiwoo Park, John Mark Awad, Dawei Jiang, David J. Dowling, Hyung-Jun Im
ACS Nano. 2025;19(23):23491–23515 Link
3687. Redefining HER2 in Breast Cancer: From Conventional Positivity to Low and Ultralow in the New Era of Antibody-Drug Conjugates
Koh J, Im SA
Cancer research and treatment [Epub ahead of print] Link
3686. Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)
Im SA, Park K, Koh J, Park C, Jung KH, Lee J, Ahn HK, Lee A, Sim SH, Kim MH, Kim JH, Kim JH, Lee KE, Park KH, Bae J, Lee MH, Lim S, Kim HJ, Lee DW, Jeong JH, Lee KS, Sohn J, Suh KJ, Kim JY, Cha YJ, Moon J, Ock CY, Kim SB, Shin K, Chae H, Kim GM, Lee KH, Park WY, Park YH, Park IH;
ESMO Open 10(10):105804. Link